3 line items for montelukast 10MG tablet. Awarded for a base year of 5/10/2026 to 5/9/2027 plus 4 one-year option periods.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0007
- Awardee
-
Xlcare Pharmaceuticals Inc. UEI MEAUS5WHBJJ7
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Montelukast 10mg Tablet (VA-25-00102867) Pre-Solicitation · 36E79725R0061 · Posted Sep 12, 2025
- Last date to order 48% complete
- IDV ceiling
- $24,826,671.05
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Xlcare Pharmaceuticals Inc. on May 10, 2026, with a ceiling of $24.8 million, for three line items of Montelukast 10mg tablets.
Xlcare Pharmaceuticals Inc. is certified as an economically disadvantaged woman-owned small business and a minority-owned, small disadvantaged business.
The contract covers a base year from May 10, 2026, through May 9, 2027, plus four one-year option periods, extending through May 9, 2031. The solicitation, issued under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals), required offerors to provide products with unique NDC numbers and exclusive contractor labeling, packaged in safety-cap bottles with specified dimensions (minimum 120cc volume, cylindrical design with 5.75-inch minimum circumference) compatible with 5.25-inch by 2-inch labels. The procurement serves the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center through the VA and DoD Pharmaceutical Prime Vendor Programs. Estimated annual quantities included 62,485 units of 30-count bottles, 699,070 units of 90-count bottles, and either 77,256 units of 500-count bottles or 38,628 units of 1000-count bottles. The contract was awarded to a single responsible offeror capable of providing uninterrupted supply. This procurement utilized no set-aside designation.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0007?
36E79726D0007 was awarded to Xlcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on May 10, 2026.
How much is contract 36E79726D0007 worth?
36E79726D0007's own ceiling is $24,826,671.
Who can order from contract 36E79726D0007?
36E79726D0007 is a single award indefinite delivery contract.
Was contract 36E79726D0007 competed?
The extent of competition for 36E79726D0007 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV